The Enterprise Value as of November 2024 (TTM) for ORIC Pharmaceuticals, Inc. (ORIC) is 622.03M

According to ORIC Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 622.03M. This represents a change of 15.89% compared to the average of 536.73M of the last 4 quarters.

ORIC Pharmaceuticals, Inc. (ORIC) Historical Enterprise Value (quarterly & annually)

How has ORIC Enterprise Value performed in the past?

The mean historical Enterprise Value of ORIC Pharmaceuticals, Inc. over the last ten years is 500.65M. The current 622.03M Enterprise Value has changed 12.32% with respect to the historical average. Over the past ten years (40 quarters), ORIC's Enterprise Value was at its highest in in the December 2020 quarter at 1.06B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

ORIC Pharmaceuticals, Inc. (ORIC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ORIC Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ORIC Pharmaceuticals, Inc. (ORIC) Average Enterprise Value

How has ORIC Enterprise Value performed in the past?

The current Enterprise Value of ORIC Pharmaceuticals, Inc. (ORIC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ORIC Pharmaceuticals, Inc. (ORIC) Enterprise Value vs. Peers

How is ORIC’s Enterprise Value compared to its peers?

ORIC Pharmaceuticals, Inc.’s Enterprise Value is greater than Seer, Inc. (117.39M), greater than Anebulo Pharmaceuticals, Inc. (45.92M), less than Cullinan Oncology, Inc. (815.05M), greater than C4 Therapeutics, Inc. (459.57M), less than Molecular Partners AG (0), greater than Mineralys Therapeutics, Inc. (57.63M), greater than AN2 Therapeutics, Inc. (603.95M), greater than Pharvaris N.V. (5.46M), less than PepGen Inc. (838.17M), greater than Werewolf Therapeutics, Inc. (171.03M), greater than Edgewise Therapeutics, Inc. (1.89M), less than Decibel Therapeutics, Inc. (3.19B), greater than Celcuity Inc. (96.42M), less than Theseus Pharmaceuticals, Inc. (641.13M), greater than PMV Pharmaceuticals, Inc. (138.26M), greater than Enliven Therapeutics, Inc. (48.39M), less than Immuneering Corporation (1.22B), greater than null (-252222.00),

Build a custom stock screener for ORIC Pharmaceuticals, Inc. (ORIC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ORIC Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ORIC Pharmaceuticals, Inc. (ORIC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ORIC Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.